Humanity is closer to stopping HIV, and the biggest obstacle is the price of the drug that will do it
Briefly

from english.elpais.com1 month ago
Lenacapavir, an antiviral drug, demonstrated 100% efficacy in preventing new HIV infections in women with just two annual subcutaneous injections. The results were presented at the IAS Conference and published in The New England Journal of Medicine.
english.elpais.comhttps://english.elpais.com/science-tech/2024-07-25/humanity-is-closer-to-stopping-hiv-and-the-biggest-obstacle-is-the-price-of-the-drug-that-will-do-it.html
The drug, similar to a vaccine, received a standing ovation at the conference, signaling a historic moment in the battle against HIV. Gilead's opportunity to make a significant impact on ending AIDS is highly anticipated.
english.elpais.comhttps://english.elpais.com/science-tech/2024-07-25/humanity-is-closer-to-stopping-hiv-and-the-biggest-obstacle-is-the-price-of-the-drug-that-will-do-it.html
Read at english.elpais.com
#hiv-prevention #lenacapavir #public-health #aids #medical-breakthroughs
[
]
[
|
]